Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels.

Autor: O'Neil A; IQVIA, Cambridge, Massachusetts., Calderbank S; IQVIA, Cambridge, Massachusetts., Brown J; IQVIA, Cambridge, Massachusetts., Vandigo J; Novartis Pharmaceutical Corporation, East Hanover, New Jersey., Yin P; Novartis Pharmaceutical Corporation, East Hanover, New Jersey.; Now with Bristol Myers Squibb, Princeton, New Jersey., Bratti K; Novartis Pharmaceutical Corporation, East Hanover, New Jersey., Howell S; Novartis Pharmaceutical Corporation, East Hanover, New Jersey.; Now with Blue Line Advisors LLC, Columbus, Ohio.
Jazyk: angličtina
Zdroj: JAMA network open [JAMA Netw Open] 2022 Nov 01; Vol. 5 (11), pp. e2240513. Date of Electronic Publication: 2022 Nov 01.
DOI: 10.1001/jamanetworkopen.2022.40513
Databáze: MEDLINE